Last reviewed · How we verify
NCT04458155
Li-Hep vs. Non-Li-Hep Coated Transfer Device
trial testing Siemens® Point-of-care high sensitive troponin I analyzer in Acute Coronary Syndrome in 70 participants. Completed in 1 April 2021.
19 December 2020
Quick facts
| Lead sponsor | VieCuri Medical Centre |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 18 June 2020 |
| Primary completion | 19 December 2020 |
| Estimated completion | 1 April 2021 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Siemens® Point-of-care high sensitive troponin I analyzer
Conditions studied
- Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
- Chest Pain — all drugs for Chest Pain →
- Myocardial Infarction — all drugs for Myocardial Infarction →
- Cardiac Ischemia — all drugs for Cardiac Ischemia →
Sponsor
VieCuri Medical Centre
Who can join
18 and older, any sex, with Acute Coronary Syndrome or Chest Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective, diagnostic, cohort study within the standard care of acute coronary syndrome (ACS) patients. It compares the analytical performance of Siemens® point-of-care high sensitive troponin I testing in venous, plasma and capillary sample types. The investigators hypothesize that there is a good correlation between the Siemens® POC HS cTnI assay results for the three sample types and that the bias between different POC sample types reduces from \~10% to ≤ 5% when using heparinized transfer device for the capillary sample.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04458155
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Coronary Syndrome
Currently open trials in the same condition.
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
- NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
- NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting
Other VieCuri Medical Centre trials
Trials by the same sponsor.
- NCT06520085 — Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application · NA · not yet recruiting
- NCT05331196 — Prognostic Value of Effort-independent Cardiopulmonary Exercise Test Variables for Postoperative Complications After Ele · completed
- NCT05483179 — Association Between New Effort-independent Cardiopulmonary Exercise Test Variables and Postoperative Complications After · completed
- NCT05353127 — Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment · completed
- NCT04904107 — Improving the Accuracy of Referrals of Patients With Chest Pain · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04458155 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VieCuri Medical Centre
- Last refreshed: 10 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04458155.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing